NanoViricides files prospectus for $50M mixed shelf
Published on: June 6, 2026, 3:21 p.m. | Source: scanx.trade
NanoViricides has filed a prospectus for a $50M mixed shelf offering with the SEC, enabling the issuance of various securities over time. The registration offers flexibility for future capital raises, covering common stock, preferred stock, debt securities, and warrants. This strategic move allows the company to access funds efficiently for general corporate purposes or acquisitions as needed.
